Inactive Instrument

Highlights Novoheart Holdings Inc. Deutsche Boerse AG

Equities

3NH

CA67011V1076

Highlights

Unlock all the news: Be the first to know and act before the market!

Novomed Limited completed the acquisition of 12.6% stake in Novoheart Holdings Inc..	18/20/18	CI
Novomed Limited entered into a definitive arrangement agreement to acquire 12.6% stake in Novoheart Holdings Inc. for CAD 12.6 million.	15/20/15	CI
Novoheart Holdings Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	31/20/31	CI
Novoheart Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	19/20/19	CI
Novoheart Announces the Completion of a Research and Development Contract Sponsored by a Top 10 Global Pharma	21/20/21	CI
Novoheart Announces an Exclusive Licensing Agreement with Harvard University's Office of Technology Development	16/19/16	CI
Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca	26/19/26	CI
Novoheart Holdings Inc. Reports Earnings Results for the First Quarter Ended September 30, 2019	19/19/19	CI
Novoheart Holdings Inc. Demonstrates Advanced Capabilities for Drug Screening as Well as Disease Modeling Which Can Lead to Safer Drugs with Better Efficacy, According to New Research	09/19/09	CI
Novoheart Holdings Inc. Reports Earnings Results for the Full Year Ended June 30, 2019	05/19/05	CI
Novoheart Holdings Inc. completed the acquisition of Xellera Therapeutics Limited from Ruby Fame Limited, Marine Bridge International Limited and Ronald Li.	28/19/28	CI
Novoheart Holdings Inc. entered into a definitive agreement to acquire Xellera Therapeutics Limited from Ruby Fame Limited, Marine Bridge International Limited and Ronald Li for CAD 32.6 million.	28/19/28	CI
Novoheart Holdings Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2019	18/19/18	CI
Novoheart Holdings Inc. Reports Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2018	02/19/02	CI
Novoheart Holdings Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2018	23/18/23	CI
Novoheart Enters into A Service Agreement with Xellera Therapeutics Limited	31/18/31	CI
Novoheart Holdings Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2018	23/18/23	CI
Novoheart Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	12/18/12	CI
Novoheart to Debut New Human Heart-in-a-Jar 2.0 Technology At the 2018 International Society for Stem Cell Research Annual Meeting	02/18/02	CI
Novoheart Files Patent Application on Disease Modeling Based on Landmark Research	29/18/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Novoheart Holdings Inc. Deutsche Boerse AG

Equities

3NH

CA67011V1076

Highlights

Filters